Gene: VAX2
Official Full Name: ventral anterior homeobox 2provided by HGNC
Gene Summary: This gene encodes a homeobox protein and is almost exclusively expressed in the ventral portion of the retina during development. In mouse studies, this gene was found to be required for the correct formation of the optic fissure and other aspects of retinal development. [provided by RefSeq, Sep 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28775 | VAX2 Knockout cell line (HEK293) | Human | VAX2 | 1:3~1:6 | Negative | Online Inquiry |
KO28776 | VAX2 Knockout cell line (A549) | Human | VAX2 | 1:3~1:4 | Negative | Online Inquiry |
VAX2 Gene Knockout Cell Lines are specifically engineered human cell lines in which the VAX2 gene has been disrupted, allowing researchers to study the functional roles of this gene in various biological processes. These cell lines employ CRISPR-Cas9 technology, a cutting-edge genome editing technique that enables precise modifications within the cellular DNA. The knockout of the VAX2 gene provides a powerful tool for investigating its involvement in cellular signaling pathways, development, and potentially in disease mechanisms such as cancer and neurodevelopmental disorders.
The primary function of the VAX2 Gene Knockout Cell Lines lies in their ability to model conditions that arise from the loss of VAX2 expression. The disruption of the gene not only elucidates its biological function but also aids in identifying downstream signaling cascades and genetic networks that are affected. Furthermore, researchers can employ these cell lines in pharmacological studies to assess how drug responses may differ in VAX2-deficient conditions versus normal cellular environments.
Scientifically, VAX2 Gene Knockout Cell Lines have far-reaching implications in both basic and applied research, including the development of therapeutic strategies for diseases linked to VAX2 dysfunction. These cell lines are invaluable in drug discovery and the development of gene therapies aimed at correcting VAX2-related pathologies.
Compared to traditional knockout methods, our VAX2 Gene Knockout Cell Lines offer enhanced specificity, reproducibility, and efficiency, significantly reducing the time and resources required for gene functional studies. This addresses critical limitations associated with earlier generations of knockout models, leading to more reliable and interpretable data.
For researchers and clinicians alike, the insights gained from using VAX2 Gene Knockout Cell Lines can translate to advanced understanding and innovative solutions in genetic and regenerative medicine. The ability to explore gene functions quickly and accurately positions this product as an essential asset in contemporary biological research.
Our company, with years of expertise in genetic engineering and cellular biology, is dedicated to providing high-quality biological products that empower scientists and healthcare professionals. We pride ourselves on leveraging cutting-edge technology to deliver products that enhance research capabilities and drive scientific discoveries forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.